MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Search

Avita Therapeutics Inc

Fermé

4.14 7.25

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.7800000000000002

Max

4.18

Chiffres clés

By Trading Economics

Revenu

-3.3M

-13M

Ventes

-1.4M

17M

Marge bénéficiaire

-77.289

Employés

260

EBITDA

-3.2M

-11M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+15.68% upside

Dividendes

By Dow Jones

Prochains Résultats

12 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.1M

119M

Ouverture précédente

-3.11

Clôture précédente

4.14

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Avita Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 janv. 2026, 21:55 UTC

Résultats

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 janv. 2026, 23:52 UTC

Résultats

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 janv. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 janv. 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 janv. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 janv. 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 janv. 2026, 22:37 UTC

Market Talk
Acquisitions, Fusions, Rachats

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 janv. 2026, 21:59 UTC

Acquisitions, Fusions, Rachats

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

22 janv. 2026, 21:44 UTC

Résultats

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 janv. 2026, 21:32 UTC

Acquisitions, Fusions, Rachats

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 janv. 2026, 21:31 UTC

Acquisitions, Fusions, Rachats

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 janv. 2026, 21:31 UTC

Acquisitions, Fusions, Rachats

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 janv. 2026, 21:30 UTC

Résultats

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

Capital One To Acquire Brex >COF

22 janv. 2026, 21:13 UTC

Résultats

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 janv. 2026, 21:11 UTC

Résultats

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 janv. 2026, 21:11 UTC

Résultats

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 janv. 2026, 21:10 UTC

Résultats

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 janv. 2026, 21:06 UTC

Résultats

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Rev $15.58B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q EPS $3.26 >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Net Interest Margin 8.26% >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Net $2.13B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Adj EPS $3.86 >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Net Charge-Offs $3.8B >COF

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q EPS $2.21 >ISRG

Comparaison

Variation de prix

Avita Therapeutics Inc prévision

Objectif de Prix

By TipRanks

15.68% hausse

Prévisions sur 12 Mois

Moyen 4.5 USD  15.68%

Haut 5.5 USD

Bas 3.5 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

1

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

8.83 / 9.77Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat